Evidence map›Paper›PMID 25747156›Full record

ArticleChemosphere2015

The HR96 activator, atrazine, reduces sensitivity of D. magna to triclosan and DHA.

Namrata Sengupta, Elizabeth J Litoff, William S Baldwin

Abstract read
In one paragraph

Article in Chemosphere, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Namrata SenguptaClemson University, Environmental Toxicology Program, United States.
Elizabeth J LitoffClemson University, Biological Sciences, United States.
William S BaldwinClemson University, Environmental Toxicology Program, United States; Clemson University, Biological Sciences, United States. Electronic address: Baldwin@clemson.edu.
Clemson University · US

Funding

The Role of Cyp2b in Toxicant Metabolism and SensitivityR15ES017321 · NIEHS · CLEMSON UNIVERSITY · PI BALDWIN, WILLIAM S · 2009 to 2020
$1.3M
NIEHS NIH HHS ES017321NIEHS NIH HHS R15 ES017321
6 · The paper itself

Abstract

HR96 is a CAR/PXR/VDR ortholog in invertebrates, and a promiscuous endo- and xenobiotic nuclear receptor involved in acclimation to toxicants. Daphnia HR96 is activated by chemicals such as atrazine and linoleic acid (LA) (n-6 fatty acid), and inhibited by triclosan and docosahexaenoic acid (DHA) (n-3 fatty acid). We hypothesized that inhibitors of HR96 may block the protective responses of HR96 based on previously performed luciferase assays. Therefore, we performed acute toxicity tests with two-chemical mixtures containing a HR96 inhibitor (DHA or triclosan) and a HR96 activator (LA or atrazine). Surprisingly, results demonstrate that triclosan and DHA are less toxic when co-treated with 20-80 μM atrazine. Atrazine provides concentration-dependent protection as lower concentrations have no effect and higher concentrations cause toxicity. LA, a weaker HR96 activator, did not provide protection from triclosan or DHA. Atrazine's protective effects are presumably due to its ability to activate HR96 or other toxicologically relevant transcription factors and induce protective enzymes. Atrazine did not significantly induce glucosyltransferase, a crucial enzyme in triclosan detoxification. However, atrazine did increase antioxidant activities, crucial pathways in triclosan's toxicity, as measured through GST activity and the TROLOX equivalence assay. The increase in antioxidant capacity is consistent with atrazine providing protection from a wide range of toxicants that induce ROS, including triclosan and unsaturated fatty acids predisposed to lipid peroxidation.

Indexed as

AnimalsAtrazineDaphniaDocosahexaenoic AcidsReceptors, Cytoplasmic and NuclearTranscription FactorsTriclosanXenobioticsAtrazineDocosahexaenoic AcidsReceptors, Cytoplasmic and NuclearTranscription FactorsTriclosanXenobioticsAntioxidantsHR96MixturesNuclear receptorPesticidesPharmaceuticals

Identifiers

PMID25747156
PMCPMC4380624
OpenAlexW2075865720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.